The expression of LUM was demonstrated to be capable of distinguishing tumors from normal tissue and predicting 1-, 3-, and 5-year OS rates in patients, highlighting its involvement as a clinical diagnostic and prognostic biomarker for GC. The gene discussed is LUM; the disease is gastric cancer.